Clinical implications in the shift of syndecan-1 expression from the cell membrane to the cytoplasm in bladder cancer

BACKGROUND: To determine the diagnostic and prognostic capability of urinary and tumoral syndecan-1 (SDC-1) levels in patients with cancer of the urinary bladder. METHODS: SDC-1 levels were quantitated by enzyme-linked immunosorbent assay (ELISA) in 308 subjects (102 cancer subjects and 206 non-canc...

Descripción completa

Detalles Bibliográficos
Autores principales: Miyake, Makito, Lawton, Adrienne, Dai, Yunfeng, Chang, Myron, Mengual, Lourdes, Alcaraz, Antonio, Goodison, Steve, Rosser, Charles J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3930286/
https://www.ncbi.nlm.nih.gov/pubmed/24524203
http://dx.doi.org/10.1186/1471-2407-14-86

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3930286/
https://www.ncbi.nlm.nih.gov/pubmed/24524203
http://dx.doi.org/10.1186/1471-2407-14-86

Ejemplares similares